Providence licenses mRNA technology to China’s Everest in $100-million deal
Calgary-based Providence has secured rights to stock and profit sharing totalling up to $400 million, plus royalties, if certain milestones are met
Barbara Shecter
The Pfizer-BioNTech vaccine received full approval from the U.S. Food and Drug Administration…
